FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:483 August 18, 1994 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Torres, C. F.

To the Editor: Torres et al. (March 31 issue)¹ conclude that surveillance scanning of children with medulloblastoma has limited clinical value. Unfortunately, the surveillance program that they describe can hardly be considered aggressive, as evidenced by the fact that asymptomatic recurrences were detected in only 4 of the 23 patients who had recurrences. I question the adequacy of a program in which the frequency of scanning dropped from every three months to every six months after a year, just before the median time to recurrence was reached. Despite the small numbers of patients, the median survival in the patients with . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.